quote

Full identifier: http://purl.org/np/RARZxdx5w8R_LaJHHGxT64nvFHVwrQdHnn4CH07QBEZmI#quote

Minted in Nanopublication

 RARZxdx5w8 comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RARZxdx5w8...#medtherapy This medical therapy http://www.w3.org/ns/prov#wasDerivedFrom was derived from This is a local identifier minted within the nanopublication. http://purl.org/np/RARZxdx5w8...#quote This quoted text .
This is a local identifier minted within the nanopublication. http://purl.org/np/RARZxdx5w8...#quote This quoted text http://www.w3.org/ns/prov#value value (this is a literal) "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of the syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or not be warranted." .
This is a local identifier minted within the nanopublication. http://purl.org/np/RARZxdx5w8...#medtherapy This medical therapy https://schema.org/targetPopulation targetPopulation This is a local identifier minted within the nanopublication. http://purl.org/np/RARZxdx5w8...#targetpop The target group .
This is the identifier for this whole nanopublication. http://purl.org/np/RARZxdx5w8... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-04-03T09:49:43.912+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RARZxdx5w8... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RA64ptuigO... RA64ptuigO .
This is the identifier for this whole nanopublication. http://purl.org/np/RARZxdx5w8... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RARZxdx5w8... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .
This is a local identifier minted within the nanopublication. http://purl.org/np/RARZxdx5w8...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RARZxdx5w8... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RARZxdx5w8...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Leoni Bücken, 3 Apr 2021, 07:49:43 UTC

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
quote
Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of the syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or not be warranted.
Leoni Bücken
2021-04-03T07:49:43.912Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
quote
Leoni Bücken
2021-04-03T07:49:43.912Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
quote
Leoni Bücken
2021-04-03T07:49:43.912Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)